Loading…Loading content
Dental implants hold because bone grows tightly onto the surface and stays there. Many of the people who need one are also taking a drug that slows the breakdown of bone, usually for osteoporosis: alendronate or another bisphosphonate as a weekly tablet, or denosumab as an injection twice a year. Those drugs keep bone dense, which sounds like good news for an implant. They are also linked to a jaw that will not heal after dental surgery, where a patch of bone dies and stays exposed for months. So the dentist facing a patient on one of these drugs has two arguments pulling in opposite directions and no settled number behind either. Does the implant fail more often, or fail later? How often does the bone around it break down? Does it matter whether the drug was swallowed or injected, and how long it had been taken? This project reads the published studies and sets out what they can and cannot support, at the doses given for osteoporosis rather than the much larger ones used in cancer care. It is desk work: papers, a spreadsheet, and a submitted manuscript at the end of it.
Read up on how a dental implant fuses to bone and what the osteoporosis drugs do to that bone. Take one part of the question, read the papers already gathered for it, build its table, and write that section.
You apply with your university account: your CV and a motivation letter written on the platform.
Sign in to apply